Continue to slide 2 »

#21. IQVIA Holdings Inc (IQV) — 23% UPSIDE

Company Name:  IQVIA Holdings Inc
Sector:  Biotechnology

IQVIA Holdings is a provider of analytics, technology solutions and contract research services to the life sciences industry. Co. is managed through three reportable segments: Technology and Analytics Solutions, which provides information, technology solutions and real-world insights and services to life science clients; Research and Development Solutions, which primarily serves biopharmaceutical clients, engaged in research and development and provides clinical research and clinical trial services; and Contract Sales and Medical Solutions, which provides contract sales to both biopharmaceutical clients and the healthcare market. The median 12 month forward target price among analysts covering IQV is $175.0/share.

Continue to slide 2 »
Quotes delayed 20 minutes
Get Free SEC filing alerts for IQV:
IQV SEC Filing Email Alerts ServiceExternal link

21 Growth Stocks For 2021 - Page 1 | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video.